Researchers from Europe and Africa gathered in Oxford on the 27th and 28th February 2014 to share knowledge on health systems research, economics and governance in health management.
The KEMRI-Wellcome Trust Research Programme is a major Wellcome Trust’s overseas programmes. Its work has had a major influence on national and international health policy. Research spans a wide variety of topics and disciplines including research on malaria and bacterial and viral infectious diseases, work to map disease risk and intervention coverage and work on research ethics and health systems strengthening.
This discussion is centered on surveys recently done on accessibility to anti-malarial drugs globally and Artemisinin-based combination therapies (ACTs). ACTs which have been highly effective are recommended treatment for malaria but despite free or highly subsidised public sector provision, access is still poor.
Catherine discusses survey results on uptake, accessibility, pricing, subsidies, supply chains and supporting interventions to ensure effective ACT scale-up. These surveys were conducted by the global fund and Bill & Melinda Gates Foundation through its support to the ACT watch project